Enzyme defect in acute intermittent porphyria –
## **Core Concept**
Acute intermittent porphyria (AIP) is a genetic disorder caused by a deficiency of a specific enzyme involved in the biosynthesis of heme. Heme is a vital component of hemoglobin, myoglobin, and various other hemoproteins. The enzyme defect in AIP leads to the accumulation of toxic intermediates in the heme biosynthetic pathway.
## **Why the Correct Answer is Right**
The correct answer, **Porphobilinogen deaminase (PBGD)**, is the enzyme deficient in acute intermittent porphyria. PBGD is a crucial enzyme in the heme biosynthesis pathway, catalyzing the conversion of porphobilinogen to hydroxymethylbilane. A deficiency in PBGD leads to the accumulation of delta-aminolevulinic acid (ALA) and porphobilinogen, which are neurotoxic and cause the clinical manifestations of AIP, including acute abdominal pain, neuropathy, and psychiatric disturbances.
## **Why Each Wrong Option is Incorrect**
- **Option A: Aminolevulinate synthase** - This is the first enzyme in the heme biosynthesis pathway and is not directly associated with AIP. Its deficiency leads to a different condition known as X-linked sideroblastic anemia.
- **Option B: Ferrochelatase** - This enzyme catalyzes the final step of heme synthesis, inserting iron into protoporphyrin IX. A deficiency in ferrochelatase leads to erythropoietic protoporphyria, a different type of porphyria.
- **Option C: Uroporphyrinogen III synthase** - Deficiency of this enzyme leads to congenital erythropoietic porphyria, characterized by severe photosensitivity and not associated with acute intermittent porphyria.
## **Clinical Pearl / High-Yield Fact**
A key clinical pearl for AIP is that it presents with acute episodes of abdominal pain, neurological symptoms, and psychiatric disturbances without skin manifestations. Diagnosis is often confirmed by measuring the levels of ALA and porphobilinogen in urine during an acute attack. AIP is a significant condition to recognize because it can be effectively managed with glucose and hematin infusions during acute attacks.
## **Correct Answer:** . Porphobilinogen deaminase